DK3737402T5 - Modificeret protein - Google Patents

Modificeret protein Download PDF

Info

Publication number
DK3737402T5
DK3737402T5 DK19700991.3T DK19700991T DK3737402T5 DK 3737402 T5 DK3737402 T5 DK 3737402T5 DK 19700991 T DK19700991 T DK 19700991T DK 3737402 T5 DK3737402 T5 DK 3737402T5
Authority
DK
Denmark
Prior art keywords
modified protein
protein
modified
Prior art date
Application number
DK19700991.3T
Other languages
English (en)
Other versions
DK3737402T3 (en
Inventor
Helen Connaris
Jane Alexandra Potter
Original Assignee
Pneumagen Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pneumagen Ltd filed Critical Pneumagen Ltd
Application granted granted Critical
Publication of DK3737402T3 publication Critical patent/DK3737402T3/da
Publication of DK3737402T5 publication Critical patent/DK3737402T5/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/28—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Vibrionaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK19700991.3T 2018-01-09 2019-01-09 Modificeret protein DK3737402T5 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1800334.3A GB201800334D0 (en) 2018-01-09 2018-01-09 Modified protein
PCT/GB2019/050053 WO2019138222A1 (en) 2018-01-09 2019-01-09 Modified protein

Publications (2)

Publication Number Publication Date
DK3737402T3 DK3737402T3 (en) 2023-04-17
DK3737402T5 true DK3737402T5 (da) 2024-08-26

Family

ID=61190345

Family Applications (1)

Application Number Title Priority Date Filing Date
DK19700991.3T DK3737402T5 (da) 2018-01-09 2019-01-09 Modificeret protein

Country Status (10)

Country Link
US (2) US11466059B2 (da)
EP (2) EP3737402B1 (da)
JP (2) JP7532251B2 (da)
KR (1) KR20200108031A (da)
CN (1) CN111818936A (da)
CA (1) CA3087835A1 (da)
DK (1) DK3737402T5 (da)
ES (1) ES2942318T3 (da)
GB (1) GB201800334D0 (da)
WO (1) WO2019138222A1 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201800334D0 (en) * 2018-01-09 2018-02-21 Pneumagen Ltd Modified protein
GB201803197D0 (en) 2018-02-27 2018-04-11 Pneumagen Ltd Viral treatment
GB201819920D0 (en) * 2018-12-06 2019-01-23 Pneumagen Ltd Cancer treatment
GB201901057D0 (en) 2019-01-25 2019-03-13 Pneumagen Ltd Cbm uses
GB201912365D0 (en) * 2019-08-28 2019-10-09 Pneumagen Ltd Treatment
WO2021176017A1 (en) * 2020-03-05 2021-09-10 Pneumagen Ltd Treatment of viral infection
WO2024081906A1 (en) * 2022-10-14 2024-04-18 The Children's Medical Center Corporation A maps vaccine targeting group b streptococcus (gbs)
GB202315114D0 (en) * 2023-10-02 2023-11-15 Pneumagen Ltd Viral treatment
GB202418737D0 (en) * 2024-12-19 2025-02-05 Pneumagen Ltd Conjugate molecules

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2344196B1 (en) 2008-09-12 2018-11-14 University Court of The University of St Andrews Carbohydrate binding molecules
CA2937840C (en) * 2014-01-24 2022-02-15 Garry Taylor Immunomodulatory compounds
GB201616006D0 (en) 2016-09-20 2016-11-02 Univ Court Of The Univ Of St Andrews The Cell modulation
GB201616007D0 (en) 2016-09-20 2016-11-02 Univ Court Of The Univ Of St Andrews The Novel Adjuvants
GB201616009D0 (en) 2016-09-20 2016-11-02 Univ Court Of The Univ Of St Andrews The Treatment and/or prevention of sepsis
GB201800334D0 (en) * 2018-01-09 2018-02-21 Pneumagen Ltd Modified protein

Also Published As

Publication number Publication date
CN111818936A (zh) 2020-10-23
ES2942318T3 (es) 2023-05-31
JP7532251B2 (ja) 2024-08-13
CA3087835A1 (en) 2019-07-18
US20230036052A1 (en) 2023-02-02
EP4233888A2 (en) 2023-08-30
EP4233888A3 (en) 2023-10-25
JP2021511308A (ja) 2021-05-06
DK3737402T3 (en) 2023-04-17
JP2024163117A (ja) 2024-11-21
US20210070814A1 (en) 2021-03-11
US11466059B2 (en) 2022-10-11
EP3737402B1 (en) 2023-03-15
WO2019138222A1 (en) 2019-07-18
GB201800334D0 (en) 2018-02-21
EP3737402A1 (en) 2020-11-18
KR20200108031A (ko) 2020-09-16

Similar Documents

Publication Publication Date Title
EP3801265B1 (en) URINARY FLOWMETER
FIC20253006I1 (fi) Linvoseltamabi
EP3890716A4 (en) COMBINATION THERAPIES
EP3849534A4 (en) COMBINATION THERAPIES
EP3846674C0 (en) VAGINAL SPECULUM
EP3555124C0 (en) TCR NYESO
IL281804A (en) Protein purification methods
MA53616A (fr) Protéines bispécifiques modifiées
DK3737403T3 (da) Modificerede adenovira
EP3781060A4 (en) CRYOPROBE
EP3872558A4 (en) OPTICAL ISOLATOR
EP3784463A4 (en) Fluorosulfones
EP3810860C0 (en) COUPLER
GB201800334D0 (en) Modified protein
EP3792200A4 (en) TANK TANK
EP3878374A4 (en) OKKLUDER
EP3721129C0 (en) Cryosphere
EP3740501A4 (en) FUSION PROTEIN EXTENSIONS
EP3609527C0 (en) PROTEIN CONJUGATES
EP3844177A4 (en) COMBINATION THERAPIES
DK3587968T3 (da) Fluidsystem
DK3752258T3 (da) Trampolin
EP3647426A4 (en) FUSION PROTEIN
PL3880011T3 (pl) Sposób
DK3837273T3 (da) Forbedret proteingenvinding